Navigation Links
Pathology Reports Good for Breast Cancer Studies
Date:2/7/2008

Harvard docs say this way of checking estrogen-receptor status of participants is OK

THURSDAY, Feb. 7 (HealthDay News) -- In epidemiological studies of women with breast cancer, pathology reports offer an acceptable alternative to repeated central laboratory testing for determining the estrogen-receptor status of participants, new research suggests.

The use of pathology reports is common practice in such studies, but it wasn't known whether they were accurate, according to the report in a recent issue of the Journal of the National Cancer Institute. Misclassification of estrogen-receptor status could seriously affect study results.

In this study, researchers at Beth Israel Deaconess Medical Center in Boston assessed the reliability of estrogen-receptor results in pathology reports by comparing them to the results of tests performed by a central laboratory.

The results were the same for 1,615 (87.3 percent) of the 1,851 samples checked in the study. This is a high rate of agreement, according to the researchers.

"Our findings, therefore, indicate that using [estrogen-receptor] assay results from pathology reports is a reasonable alternative to using central laboratory testing to obtain [estrogen- receptor] results in large, population-based studies of women with breast cancer," the study authors concluded.

More information

The American Cancer Society has more about breast cancer.



-- Robert Preidt



SOURCE: Journal of the National Cancer Institute news release, Jan. 29, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Congressman Hoekstra Tours Holland Pathology Laboratory; Learns Vital Role In Patient Care
2. Congressman Davis to Tour Pathology Laboratory, Learn Critical Role in Patient Care
3. Springer founds new electronic journal Head and Neck Pathology
4. Xceed Molecular Launches Ziplex(R) Automated Gene-Expression System at the Association for Molecular Pathology, Booth 84/85
5. Leaders in Pathology Meet in Chicago: Sept. 30 - Oct. 3, 2007
6. American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter
7. J.D. Power and Associates Reports: The Nebraska Medical Center Recognized for Providing an Outstanding Inpatient Experience for a Third Consecutive Year, and for Providing an Outstanding Cardiovascular Experience
8. HCA Reports Fourth Quarter - Year End 2007 Results
9. MedCath Corporation Reports First Quarter Earnings
10. DRAXIS Health Reports Fourth Quarter and Year End Results
11. PPD Reports Fourth Quarter and Year-End 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pathology Reports Good for Breast Cancer Studies
(Date:2/5/2016)... SARASOTA, Florida (PRWEB) , ... February 05, 2016 , ... ... an event he has completed every year since it started in 2003. This year, ... attracting the attention of fellow runners and NBA team the Miami Heat. , This ...
(Date:2/5/2016)... ... February 05, 2016 , ... Successful recruitment and ... clinical and scientific initiatives have all marked the last 12 months at Roswell ... CEO of the nation’s oldest cancer center, Candace S. Johnson, PhD, outlined the ...
(Date:2/5/2016)... New York, New York (PRWEB) , ... February 05, 2016 , ... ... your life? The answer may be at the tips of your toes. Foot massage, ... benefits as well as pure comfort and relaxation. The American Board of Multiple ...
(Date:2/5/2016)... Rafael, CA (PRWEB) , ... February 05, 2016 , ... ... with ChildLight Yoga Studio in Dover, NH to direct high-performance kids yoga training. ChildLight ... New Hampshire’s seacoast, just one hour from Boston. , ChildLight Yoga Studio founder Lisa ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure ... to search for and donate to Give To Cure’s campaign that is crowdfunding clinical ... lets users make and share payments through a smart device. In 2015 alone, Venmo ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Feb. 4, 2016 Global Immunology Market ... to drive long-term market growth Summary ... of chronic disorders that affect 5–7% of western ... of their symptoms and key patient demographics, they ... immune pathways and an inappropriate immune response. Generally, ...
(Date:2/4/2016)... -- Omnicell, Inc. (NASDAQ: OMCL ), a leading provider of ... announced results for its fiscal year and fourth quarter ... --> GAAP results: Revenue for the fourth quarter ... 4.1% from the third quarter of 2015, and up ... 2014. Revenue for the year ended December 31, 2015 was ...
(Date:2/4/2016)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... treat life-threatening diseases, today announced results for the ... 2015. --> --> ... our last quarterly call, we strategically advanced pre-clinical ... to establish the Aethlon Hemopurifier® as a leading ...
Breaking Medicine Technology: